Researchers from the University of Queensland, in collaboration with the University of Minnesota, have made significant strides in understanding depression by investigating the levels of adenosine triphosphate (ATP), often referred to as the "energy currency" molecule, in the brains and blood cells of young individuals diagnosed with depression.
Associate Professor Susannah Tye from UQ's Queensland Brain Institute (QBI) emphasized that this research represents the first instance where patterns of these energy-related molecules have been identified in both the brain and bloodstream of individuals suffering from major depressive disorder (MDD).
"The findings suggest that symptoms of depression may stem from fundamental shifts in how brain and blood cells utilize energy," Dr. Tye noted. "Fatigue is a prevalent and challenging symptom of MDD, often taking years for individuals to discover effective treatments."
"Limited advancements in new therapies have occurred due to insufficient research, and we believe this breakthrough could pave the way for earlier interventions and more precise treatment options," she added.
Study Involves Brain Imaging and Blood Analysis
The study involved a comprehensive analysis conducted at the University of Minnesota, where brain scans and blood samples were collected from 18 participants aged 18 to 25 diagnosed with MDD.
Subsequently, the Queensland Brain Institute researchers analyzed these samples and compared them with those from individuals without depression.
Unexpected Energy Dynamics in Cells
Dr. Roger Varela from QBI reported that the team discovered an intriguing energy production pattern in the cells of participants with depression. These cells demonstrated elevated levels of energy molecules while at rest but encountered difficulties in enhancing energy production during stress.
"This indicates that cells may be overexerting themselves early in the condition, potentially leading to long-term complications," Dr. Varela explained. "This was unexpected, as one might assume that energy production would be lower in individuals with depression."
"Our findings imply that during the initial phases of depression, the mitochondria in both the brain and body may struggle to meet higher energy demands, contributing to symptoms such as low mood, diminished motivation, and slower cognitive function."
Implications for Understanding and Treating Depression
Dr. Varela also expressed that this research could reshape perceptions of depression. "It reveals that multiple physiological changes occur, affecting both the brain and blood, and that depression influences energy at a cellular level," he stated.
"Moreover, it highlights that not all cases of depression are identical; each patient possesses unique biological characteristics, and their experiences vary significantly."
The study, led by Katie Cullen MD at the University of Minnesota, utilized an imaging technique developed by Professors Xiao Hong Zhu and Wei Chen to assess ATP production in the brain. The findings are published in Translational Psychiatry.
